Sanofi, Whistleblower Settle 19-Year Cancer Drug FCA Battle
A whistleblower has voluntarily dropped his 19-year-old False Claims Act lawsuit alleging the drugmaker Sanofi U.S. Services Inc. misleadingly promoted off-label uses for its cancer therapy drug, after the parties reached...To view the full article, register now.
Already a subscriber? Click here to view full article